Department of Therapeutic Chemistry, National Research Centre, Dokki, Cairo 12622, Egypt.
Department of Photochemistry, National Research Centre, Dokki, P.O. Box.12622, Cairo, Egypt.
Anticancer Agents Med Chem. 2021;21(10):1323-1333. doi: 10.2174/1871520620666200929155246.
BACKGROUND & OBJECTIVE: Glycosyl heterocycles, being as nucleoside analogs with modified glycon and hybrid heterocycle motifs, are of considerable interest, and thus, the targeted compounds were synthesized via a convenient and efficient approach.
New indolyl-thiadiazolyl thioglycosides scaffolds were synthesized, starting with the reaction of indole-3-carbaldehyde with 2-aminothiadiazole-5-thiole followed by glycosylation and deprotection. Likewise, new molecular hybrids comprising indole, thiadiazole, triazole and glycosyl moieties were synthesized utilizing click chemistry strategy. The cytotoxic activities of the newly synthesized compounds were studied on colon carcinoma HCT116, breast carcinoma MCF-7, lung carcinoma A549 and hepatocellular carcinoma HepG2 cell lines using Sulphorhodamine-B (SRB) assay.
The 1,3,4-thiadiazole thioglycoside and the 1,2,3-triazole N-glycoside possessing xylose moiety, compounds 8 and 15 revealed the most potent bio-activity among the new chemical entities; therefore, they undertook for further analysis of apoptosis.
ICs of Compound 8 were 38, 36, 33 and 158μg/ml, while they were 41, 44, 32 and 25μg/ml for compound 15 on HepG2, MCF7, HCT116 and A549 cell lines, respectively; furthermore, the total apoptosis rate (%) for control untreated cells were 9.63, 28.4, 25.4 (%), compounds 8 and 15 respectively, they produced a significant increase in total and early apoptosis rate (%) compared to control (P=0.0001). At the same time, no significant difference was detected in the late apoptosis rate (%), which means that both derivatives have the potential to be developed into potent anticancer agents.
糖基杂环化合物作为具有修饰糖基和杂环结构的核苷类似物,具有重要的研究意义。因此,我们通过一种便捷高效的方法来合成目标化合物。
以吲哚-3-甲醛与 2-氨基-5-巯基噻二唑反应为起始原料,通过糖苷化和脱保护反应,合成了新型吲哚基-噻二唑基硫代糖苷骨架。同样,利用点击化学策略,合成了包含吲哚、噻二唑、三唑和糖基部分的新型分子杂合体。采用磺基罗丹明 B(SRB)法研究了新合成化合物对结肠癌细胞株 HCT116、乳腺癌 MCF-7、肺癌 A549 和肝癌 HepG2 的细胞毒性。
1,3,4-噻二唑硫代糖苷和 1,2,3-三唑 N-糖苷(含木糖基)化合物 8 和 15 表现出最强的生物活性,因此,它们被进一步用于研究细胞凋亡。
化合物 8 的 IC50 值分别为 38、36、33 和 158μg/ml,化合物 15 的 IC50 值分别为 41、44、32 和 25μg/ml,在 HepG2、MCF7、HCT116 和 A549 细胞系中,与对照组未处理的细胞相比,总凋亡率(%)分别为 9.63、28.4、25.4(%),化合物 8 和 15 分别显著增加了总凋亡率(%)和早期凋亡率(%)(P=0.0001)。同时,晚期凋亡率(%)没有显著差异,这意味着这两个衍生物都有可能被开发成有效的抗癌药物。